Clinical trial
A Randomized Controlled Trial of Methylprednisolone Versus Standard of Care in Patients Undergoing Major Hepatectomy
NCT07507643 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Controlled Trial of Methylprednisolone Versus Standard of Care in Patients Undergoing Major Hepatectomy
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- March 27, 2026
- Completion date
- March 27, 2029
- Enrollment
- 750 (estimated)
- Sites
- 19
Conditions
As the registry lists them; a condition with its own page is linked.
hepatectomy